A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1007/s00280-017-3439-x
Published Online: 2017-11-09
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sakurai, Reiko
Tomizawa, Yoshio
Yoshii, Akihiro
Miura, Yosuke
Tsurumaki, Hiroaki
Kaira, Kyoichi
Sunaga, Noriaki
Kawashima, Osamu
Hisada, Takeshi
Yamada, Masanobu
Saito, Ryusei
License valid from 2017-11-09